| Literature DB >> 28392146 |
Xin Niu1, Hetal Brahmbhatt2, Philipp Mergenthaler3, Zhi Zhang4, Jing Sang5, Michael Daude6, Fabian G R Ehlert6, Wibke E Diederich6, Eve Wong7, Weijia Zhu7, Justin Pogmore8, Jyoti P Nandy9, Maragani Satyanarayana9, Ravi K Jimmidi10, Prabhat Arya9, Brian Leber11, Jialing Lin4, Carsten Culmsee12, Jing Yi13, David W Andrews14.
Abstract
Aberrant apoptosis can lead to acute or chronic degenerative diseases. Mitochondrial outer membrane permeabilization (MOMP) triggered by the oligomerization of the Bcl-2 family proteins Bax/Bak is an irreversible step leading to execution of apoptosis. Here, we describe the discovery of small-molecule inhibitors of Bax/Bak oligomerization that prevent MOMP. We demonstrate that these molecules disrupt multiple, but not all, interactions between Bax dimer interfaces thereby interfering with the formation of higher-order oligomers in the MOM, but not recruitment of Bax to the MOM. Small-molecule inhibition of Bax/Bak oligomerization allowed cells to evade apoptotic stimuli and rescued neurons from death after excitotoxicity, demonstrating that oligomerization of Bax is essential for MOMP. Our discovery of small-molecule Bax/Bak inhibitors provides novel tools for the investigation of the mechanisms leading to MOMP and will ultimately facilitate development of compounds inhibiting Bax/Bak in acute and chronic degenerative diseases.Entities:
Keywords: Bak; Bax; Bcl-2 family; apoptosis; excitotoxicity; mitochondrial outer membrane permeabilization; programmed cell death; small-molecule inhibitors
Mesh:
Substances:
Year: 2017 PMID: 28392146 PMCID: PMC6508953 DOI: 10.1016/j.chembiol.2017.03.011
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116